Medication treatment for opioid use disorder among rural primary care patients

被引:1
|
作者
Hser, Yih-Ing [1 ,6 ]
Zhu, Yuhui [1 ]
Baldwin, Laura-Mae [2 ]
Mooney, Larissa J. [1 ,3 ]
Saxon, Andrew J. [4 ,5 ]
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Univ Washington, Dept Family Med, Seattle, WA USA
[3] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[4] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA
[5] Univ Washington, Dept Psychiat & Behav Sci, Sch Med, Seattle, WA USA
[6] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, 10911 Weyburn Ave,Suite 200, Los Angeles, CA 90024 USA
来源
JOURNAL OF RURAL HEALTH | 2024年 / 40卷 / 01期
基金
美国国家卫生研究院;
关键词
medication treatment for opioid use disorder; opioid use disorder; primary care; rural primary care;
D O I
10.1111/jrh.12785
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeTo investigate the prevalence of opioid use disorder (OUD) and medication treatment for OUD (MOUD) receipt in rural primary care settings and identify characteristics associated with MOUD among patients with OUD. MethodsSecondary analyses based on electronic health records of all adult patients who visited 1 of the 6 rural primary care clinic sites from October 2019 to January 2021. Mixed effects logistic regression was conducted to assess MOUD receipt (Y/N) in relation to patient characteristics (eg, demographics, other substance use disorders [SUDs], mental health disorders, and chronic pain) and the number of MOUD prescribers per clinic. FindingsThe prevalence of OUD varied from 0.7% to 8.2% (Mean [SD] = 3.3% [95% CI: 0.4, 6.1]) among 36,762 primary care patients across 6 clinic sites. Among 1,164 patients with OUD, on average 50.1% received MOUD (95% CI: 28.0, 72.3). Patients in clinics with more than 3 MOUD prescribers had more than 3 times the odds of receiving MOUD (OR = 3.42; 95% CI, 1.22-9.62) as those in clinics with fewer than 3 prescribers. MOUD was positively associated with younger age (18-30 [OR = 6.97; 95% CI, 3.37-14.42], 31-64 [OR = 5.03; 95% CI, 2.64-9.57], relative to those 65 and older), having other co-occurring SUDs (OR = 3.77; 95% CI, 2.57-5.52), being male (OR = 1.50; 95% CI, 1.12-2.01), and negatively associated with having chronic pain disorders (OR = 0.69; 95% CI, 0.50-0.94). ConclusionsThe prevalence of OUD and MOUD are high but vary considerably across rural primary care clinics; primary care MOUD prescribers play a key role on MOUD access in rural settings.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 50 条
  • [41] Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
    Cantone, Rebecca E.
    Garvey, Brian
    O'Neill, Allison
    Fleishman, Joan
    Cohen, Deborah
    Muench, John
    Bailey, Steffani R.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (05) : 724 - 731
  • [42] Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings
    Hooker, Stephanie A.
    Starkey, Colleen
    Bart, Gavin
    Rossom, Rebecca C.
    Kane, Sheryl
    Olson, Anthony W.
    BMC PRIMARY CARE, 2024, 25 (01):
  • [43] Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care
    Krupp, Joanna
    Hung, Frances
    LaChapelle, Tina
    Yarrington, Michael E.
    Link, Katherine
    Choi, Yujung
    Chen, Hillary
    Des Marais, Andrea
    Sachdeva, Nidhi
    Chakraborty, Hrishikesh
    McKellar, Mehri S.
    SOUTHERN MEDICAL JOURNAL, 2023, 116 (04) : 333 - 340
  • [44] SLEEP MEDICATION PRESCRIBING AMONG PATIENTS RECEIVING OPIOID USE DISORDER TREATMENT WITH COMORBID INSOMNIA
    Martin, Caitlin
    Patel, Hetal
    Dzierzewski, Joseph
    Moeller, Frederick
    Bierut, Laura
    Grucza, Richard
    Xu, Kevin
    SLEEP, 2023, 46 : A297 - A297
  • [45] Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review
    Carr, Meagan M.
    Lou, Raissa
    Macdonald-Gagnon, Grace
    Peltier, MacKenzie R.
    Funaro, Melissa C.
    Martino, Steve
    Masheb, Robin M.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2023, 49 (05): : 551 - 565
  • [46] Neonatal Outcomes Among Patients Taking Medication for Opioid Use Disorder
    Keer, Emma
    Irani, Sanaya
    Boggan, Jordyn
    Townsel, Courtney
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 72S - 72S
  • [47] An examination of correlates of simultaneous opioid and benzodiazepine use among patients in medication treatment for opioid use disorder in a small midwestern community
    Ellis, Jennifer D.
    Pasman, Emily
    Brown, Suzanne
    Lister, Jamey J.
    Agius, Elizabeth
    Resko, Stella M.
    JOURNAL OF ADDICTIVE DISEASES, 2022, 40 (04) : 542 - 551
  • [48] Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder
    Gopaldas, Manesh
    Wenzel, Kevin
    Campbell, Aimee N. C.
    Jalali, Ali
    Fishman, Marc
    Rotrosen, John
    V. Nunes, Edward
    Murphy, Sean M.
    PSYCHIATRIC SERVICES, 2023, 74 (12) : 1227 - 1233
  • [49] Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder
    Ahrens, Katherine A.
    McBride, Carole A.
    O'Connor, Alane
    Meyer, Marjorie C.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (01) : 56 - 64
  • [50] Integrating Opioid Use Disorder Treatment Into Primary Care Settings
    Austin, Elizabeth J.
    Chen, Jessica
    Briggs, Elsa S.
    Ferro, Lori
    Barry, Paul
    Heald, Ashley
    Merrill, Joseph O.
    Curran, Geoffrey M.
    Saxon, Andrew J.
    Fortney, John C.
    Ratzliff, Anna D.
    Williams, Emily C.
    JAMA NETWORK OPEN, 2023, 6 (08) : E2328627